Jul 10, 2025 • Benzinga
NEUTRAL
This Is What Whales Are Betting On Eli Lilly - Eli Lilly ( NYSE:LLY )
Deep-pocketed investors have adopted a bullish approach towards Eli Lilly LLY, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today.
Jul 10, 2025 • Zacks Commentary
NEUTRAL
Lilly Down More Than 15% in a Year: Time to Buy, Sell or Hold?
LLY has slid 15.7% over the past year, but surging demand for Mounjaro and Zepbound could revive the stock's momentum.
Jul 10, 2025 • Zacks Commentary
SOMEWHAT-BULLISH
Pharma Companies Remain Calm Amid Fresh Tariff Threat by Trump
Trump revives tariff threats on pharma imports, but industry giants like LLY and JNJ stay unfazed with major U.S. investments underway.
Jul 10, 2025 • Zacks Commentary
BULLISH
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Jul 10, 2025 • Zacks Commentary
SOMEWHAT-BULLISH
Is Invesco Pharmaceuticals ETF ( PJP ) a Strong ETF Right Now?
Smart Beta ETF report for ...
Jul 09, 2025 • Motley Fool
NEUTRAL
3 Reasons I Bought Novo Nordisk Stock Instead of Eli Lilly
Eli Lilly ( NYSE: LLY ) and Novo Nordisk ( NYSE: NVO ) are two phenomenal growth stocks that investors probably can't go wrong with when investing in for the long term. They are leaders in the GLP-1 weight loss space, and have been generating strong growth in recent years.But while they are ...